Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2016 08:30 ET | Source: Amyris

Amyris Fuels First Delivery of New Airbus A350-900 Airplane for Cathay Pacific as Part of Two-Year Biojet Agreement

EMERYVILLE, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that, on May 29, 2016, Cathay Pacific commenced a two-year...
June 06, 2016 08:30 ET | Source: Amyris, Inc.

Amyris Announces Collaboration with Johnson & Johnson Innovation for Biosynthetic Drug Discovery

Amyris’s µPharmTM Platform to be Used for Rapid Integrated Discovery and Production of Therapeutic Compounds EMERYVILLE, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the...
May 27, 2016 08:30 ET | Source: Amyris, Inc.

Amyris to Participate in June 2016 Investor Conferences

EMERYVILLE, Calif., May 27, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
May 20, 2016 08:30 ET | Source: Amyris, Inc.

Amyris & CJ CheilJedang Corporation Creating Manufacturing and Sales Partnership

EMERYVILLE, Calif., May 20, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and South Korea-based CJ CheilJedang Corporation (“CJ”)(KRX:097950), today...
May 11, 2016 14:42 ET | Source: Amyris, Inc.

Amyris to Participate in Upcoming Investor Conferences in May 2016

EMERYVILLE, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
May 10, 2016 16:15 ET | Source: Amyris, Inc.

Amyris First Quarter 2016 Results Deliver Strong Renewable Product Sales Growth and Continued Reduction in Operating Expenses

Q1 2016 revenues of $8.8 million, including product sales growth of 50% over Q1 2015Reduced selling, general and administrative expenses by 15% and continued progress in exit from non-strategic...
May 06, 2016 08:30 ET | Source: Amyris, Inc.

Biossance™ Announces the Blacklist ─ 2,000+ Potentially Harmful Cosmetic Ingredients it Refuses to Use while Delivering Products Consumers Love to Use

EMERYVILLE, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Biossance™, the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), announced today the Blacklist ─ 2,000+ common...
April 29, 2016 08:30 ET | Source: Amyris, Inc.

Amyris to Announce First Quarter Financial Results on Tuesday, May 10, 2016

EMERYVILLE, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2016 after market close on Tuesday, May 10,...
April 27, 2016 08:30 ET | Source: Amyris, Inc.

Amyris Signs Five Year Biofene® Supply Agreement with leading Global Nutraceuticals Company with Over $100 Million of Expected Value

EMERYVILLE, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed a five year Biofene® supply agreement with...
April 25, 2016 08:30 ET | Source: Amyris, Inc.

Amyris Named Gold 2016 Edison Award Winner -- One of Highest Accolades for Innovation in Business

EMERYVILLE, Calif., April 25, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has been named a Gold Edison Award winner for its...